BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 10733541)

  • 1. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
    Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
    Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.
    Montgomery A; Ferral H; Vasan R; Postoak DW
    Cardiovasc Intervent Radiol; 2005; 28(3):307-12. PubMed ID: 15886944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center.
    Pan JJ; Chen C; Caridi JG; Geller B; Firpi R; Machicao VI; Hawkins IF; Soldevila-Pico C; Nelson DR; Morelli G
    J Vasc Interv Radiol; 2008 Nov; 19(11):1576-81. PubMed ID: 18789725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis.
    Biecker E; Roth F; Heller J; Schild HH; Sauerbruch T; Schepke M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):846-52. PubMed ID: 17873607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
    Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical shunts and TIPS for variceal decompression in the 1990s.
    Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
    Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P; Saad WE; Waldman D
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.